UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 15, 2005
ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its charter)
| Minnesota | 0-8672 | 41-1276891 |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |
| One Lillehei Plaza, St. Paul, MN | 55117 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:(651) 483-2000
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
On February 15, 2005, the Registrant issued a press release concerning the acquisition of the business of Velocimed, LLC. A copy of which is furnished herewith as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
| (c) Exhibits: |
| 99.1 | Press release issued by the Company concerning the acquisition of the business of Velocimid, LLC. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 15th day of February, 2005.
| ST. JUDE MEDICAL, INC. | |||
| By: /s/ Kevin T. O’Malley | |||
| Kevin T. O’Malley | |||
| Vice President and | |||
| General Counsel |
| Exhibit No. | Description of Exhibit | ||
|---|---|---|---|
| 99.1 | Press Release dated February 15, 2005 announcing the acquisition of the business of Velocimed, LLC. | ||
